Ken Fisher Super Stocks: 5 Biggest Small-Cap Stocks

In this article, we discuss the 5 biggest small-cap stocks in the Ken Fisher portfolio. If you want to see more stocks in this selection, check out Ken Fisher Super Stocks: 10 Biggest Small-Cap Stocks. 

5. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

Number of Hedge Fund Holders: 31

Fisher Asset Management’s Stake Value: $65,064,000

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) is a North Carolina-based biotechnology company that discovers and develops novel, oral, and small-molecule medicines. It is one of Ken Fisher’s top small-cap stock picks as of Q3 2022. Fisher Asset Management owns 5.16 million shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) worth $65 million, representing 0.04% of the total portfolio. 

On November 2, Evercore ISI analyst Liisa Bayko upgraded BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) to Outperform from In Line with a price target of $16, up from $14. The stock traded 11% lower after the company’s “sluggish quarter,” but the analyst sees this as a buying opportunity on weakness given that Orladeyo’s long-term prospects are intact despite some “short-term blips in numbers.”

According to Insider Monkey’s data, 31 hedge funds were long BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) at the end of Q2 2022, compared to 25 funds in the preceding quarter. Julian Baker and Felix Baker’s Baker Bros. Advisors is the leading stakeholder of the company, with 12.7 million shares worth $134.5 million.